AstraZeneca Says ‘No Evidence’ Of Blood Clot Risk From Vaccine

Countries like Germany, France, the UK, the Netherlands, Mexico and Nigeria have stood by the vaccine and assured citizens of its safety

The global rollout of the Oxford-AstraZeneca Covid-19 vaccine has encountered another hurdle as a handful of countries paused their use of the shot following reports it could be connected to blood clots, despite no clear evidence of a link.

AstraZeneca has robustly defended its vaccine, saying Friday there was “no evidence of an increased risk” of blood clots, and European and UK medicines regulators have each said the link between the vaccine and blood clots has not been confirmed and that rollouts should continue.

After a group of European countries – including Denmark, Norway and Iceland – suspended use of the vaccine on Thursday, Thailand’s Prime Minister, Prayut Chan-o-cha, canceled plans to publicly get the AstraZeneca shot on Friday and the country also delayed its rollout.

“When there is an adverse event, we don’t need to be in rush,” said Piyasakol Sakolsatayadorn, a senior member of the country’s vaccination committee.

Bulgaria has become the latest country to suspend use of the vaccine on Friday pending investigations into safety.

YOU MAY ALSO LIKE